Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

50 results about "Exogenous material" patented technology

An exogenous factor is any material that is present and active in an individual organism or living cell but that originated outside that organism, as opposed to an endogenous factor. Exogenous factors in medicine include both pathogens and therapeutics.

Proteins comprising amino-terminal proximal shiga toxin a subunit effector regions and cell-targeting immunoglobulin-type binding regions

InactiveUS20160376328A1Reduces and eliminates cytotoxicityFacilitates cellular internalizationAntibacterial agentsPeptide/protein ingredientsCellular pathwaysCytotoxicity
The present invention provides proteins comprising immunoglobulin-type binding regions for cell-type specific targeting and Shiga toxin A Subunit effector regions for Shiga toxin effector functions (e.g. cellular internalization, directing subcellular routing, and / or cytotoxicity), wherein the binding regions and Shiga toxin effector regions are combined such that the Shiga toxin effector regions are proximal to the amino-terminals of the proteins. The presently disclosed proteins can comprise additional exogenous materials, such as, e.g., antigens, cytotoxic agents, and detection-promoting agents, and are capable of targeted delivery of these additional exogenous materials into the interiors of target cells. The proteins of the present invention have uses in methods such as, e.g., methods involving targeted killing of target cells, delivering exogenous materials into target cells, labeling subcellular compartments of target cells, and diagnosing and / or treating a variety of conditions including cancers, tumors, other growth abnormalities, immune disorders, and microbial infections.
Owner:MOLECULAR TEMPLATES

Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal, endoplasmic reticulum localization signal motifs

InactiveUS20170002046A1Strong cytotoxicityAntibacterial agentsNervous disorderAntigenType specific
The present invention provides proteins comprising binding regions for cell-type specific targeting, Shiga toxin effector regions derived from A Subunits of members of the Shiga toxin family for providing Shiga toxin effector functions (e.g. cellular internalization and cytotoxicity), and carboxy-terminal endoplasmic reticulum localization signal motifs. The presently disclosed proteins can comprise additional exogenous materials, such as, e.g., antigens, cytotoxic agents, and detection-promoting agents, and are capable of targeted delivery of these additional exogenous materials into the interiors of target cells. The proteins of the present invention have uses in methods such as, e.g., methods involving targeted killing of target cells, delivering exogenous materials into target cells, labeling subcellular compartments of target cells, and diagnosing and / or treating a variety of conditions including cancers, tumors, other growth abnormalities, immune disorders, and microbial infections.
Owner:MOLECULAR TEMPLATES

Method for long-term storage and resuscitation culture of adult peripheral blood mononuclear cell

InactiveCN105316287AIncrease retention ratioIncreased survival rate after resuscitationDead animal preservationBlood/immune system cellsDiseaseVein
The invention discloses a method for long-term storage and resuscitation culture of adult peripheral blood mononuclear cells, and relates to a separation, cryopreservation and resuscitation method of adult peripheral blood mononuclear cells. The method comprises the following steps: I, collecting peripheral venous blood of a healthy adult by using a blood taking bag, and separating and purifying the mononuclear cells in the blood; II, adding related cryopreservation reagents necessary for cryopreservating cells so as to cryopreservate the separated mononuclear cells; III, randomly sampling, and detecting bacteria, fungi, endotoxin and mycoplasma in a cell cryopreservation mixed liquid; and IV, resuscitating the cells, suspending in specially prepared cell resuscitation lotion, performing centrifugal washing twice, and further culturing. As the peripheral blood mononuclear cells used in the method are taken from a patient self, the related reagents used in the test are free of exogenous material, related ethical issues can be avoided, and immunological rejection can be avoided after the cells are injected back to the body. The method aims to store healthy adult immune cells for later treatment on diseases related to tumor.
Owner:天晴干细胞股份有限公司

Novel tumor-associated marker

The present invention provides monoclonal antibody-producing hybridomas designated 27.F7 and 27.B1. The invention provides a method of detecting TIP-2 antigen bearing cancer cells in a sample. The invention provides a method of detecting TIP-2 antigen on the surface of cancer cells. The invention provides a method for diagnosing cancer in a subject. The invention provides a method for delivering exogenous material to TIP-2 antigen-bearing cancer cells of a human subject. The invention provides a method for treating cancer in a human subject. The invention provides isolated peptides having the amino acid sequences Lys Leu Leu Gly Gly Gln Ile Gly Leu (SEQ. ID No.) and Ser Leu Leu Gly Cys Arg His Tyr Glu Val (SEQ. ID No.). The invention provides a method for immunohistochemical screening of a tissue section for the presence of TIP-2 antigen bearing cancer cells. The invention provides a kit for detecting the presence of TIP-2 antigen-bearing cancer cells. The invention provides a method for detecting the presence of TIP-2 antigen. The invention provides a method for immunohistochemical screening of tissue sections. The invention provides a method for monitoring progression of cancer wherein the cancer cells are TIP-2 antigen-bearing cells. The invention provides a method for diagnosing cancer associated with the expression of TIP-2.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Method for constructing regenerated nerve vascularized bones, cartilages, joints or body surface organs

InactiveCN103948457ASafe treatment planEffective treatment optionsBone implantJoint implantsVascularizesHuman body
The invention relates to a method for constructing regenerated nerve vascularized bones, cartilages, joints or body surface organs by a prefabricated female die bracket. Firstly, the female die bracket of a defected tissue or organ is printed in a three-dimension manner by using a computer assisted design / manufacturing technology; then, a surface of a periosteum and / or perichondrium is formed in a body through an operation, the female die bracket is placed and fixedly sutured on a germinal layer of the autologous periosteum and / or perichondrium to form a closed space; after the bones, cartilages, joints or body surface organs whose male die shape corresponds to a female die are regenerated in the space constructed by the female die and the germinal layer of the surface of the periosteum and / or perichondrium, a newly regenerated tissue is taken out, the female die bracket is removed, and the tissue is transplanted to the position of the defected tissue or organ to reconstruct. The newly generated tissue or organ prepared through autologous prefabrication has rich new vessels and nerves, does not contain any exogenous materials participating in tissue regeneration, is high in safety, accurate in shape at the same time, and quite similar to the normal tissue or organ.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Method For Mechanical and Hydrodynamic Microfluidic Transfection and Apparatus Therefor

Methods for introducing exogenous material into a cell are provided, which include exposing the cell to a transient decrease in pressure in the presence of the exogenous material. Also provided are devices for performing the method of the invention.
Owner:INDEE INC

Technical method for co-cultivating hepatocytes and hepatic sinusoidal endothelial cells and application of technical method

The invention discloses a technical method for co-cultivating hepatocytes and hepatic sinusoidal endothelial cells and application of the technical method. The technical method is characterized in that a hepatic sinusoidal endothelial cell line is subjected to anaerobic cultivation for a certain period of time, and then the hepatic sinusoidal endothelial cell line is harvested and co-cultured witha hepatocyte line at a certain ratio. Co-culture with the hepatic sinusoidal endothelial cell line can partially simulate a liver environment in a human body, hepatocyte functions are facilitated, after the hepatic sinusoidal endothelial cells are activated by hypoxia, the ability of promoting the hepatocyte functions is enhanced, and no exogenous endothelial cell activator is needed, the introduction of exogenous materials is reduced, and subsequent cell application is facilitated. The invention further provides the application of the co-culture method in fields including drug screening, bioartificial liver preparation and the like.
Owner:苏州瑞徕生物科技有限公司

High-efficiency transfection of biological cells using sonoporation

ActiveUS10787670B2Convenient introductionConvenience to mergeUltrasound therapySugar derivativesBiological cellSonoporation
A method is provided for achieving transfection of host cells using sonoporation. An acoustic radiation generator is positioned in acoustic coupling relationship with respect to a reservoir containing host cells to be transfected, exogenous material to be incorporated into the host cells, and a cell-compatible fluid medium. The acoustic radiation generator is activated to generate acoustic radiation and direct the acoustic radiation into the reservoir in a manner effective to enable transfection of the host cells with the exogenous material.
Owner:LABCYTE

Method for the optoinjection of exogenous material into a biological cell

A method for the optoinjection of exogenous material in a recipient biological cell is disclosed and comprises: placing a biological cell on a planar surface of a substrate, transmitting a sub-ns pulsed laser beam through a variable convergence / divergence collimator; focusing the laser beam in a focal spot positioned along an axial direction substantially perpendicular to the substrate; moving the focal spot towards the cell along the axial direction by continuously varying the electric control signal from a first amplitude value a second amplitude value the second amplitude value of the control signal is selected such that the second axial position is positioned inside the cell.
Owner:FOND INST ITAL DI TECH

Device and method for conveying exogenous substances into eukaryotic cells and application of device and method

PendingCN110272810ANot affected by its own physical and chemical propertiesReduce volumeBioreactor/fermenter combinationsBiological substance pretreatmentsBiotechnologyNuclear membrane
The invention provides a device and method for conveying exogenous substances into eukaryotic cells and application of the device and method and relates to the technical field of biology. The device for conveying the exogenous substances into the eukaryotic cells comprises an extrusion module, a micropore membrane with a regular pore channel is arranged in the extrusion module, and the pore diameter of the pore channel is smaller than the diameter of the eukaryotic cells; the extrusion module further comprises a pressure unit for driving the eukaryotic cells and the exogenous substances to simultaneously pass through the pore channel. Cells suspended in a solution can be compressed and deformed in the process of penetrating through the pore channel, and accordingly punching of cell membranes and nuclear membranes is caused, so that exogenous materials dispersed or dissolved in a cell suspension solution enter the cytoplasm and cell nuclei.
Owner:GUANGZHOU VESICIN BIOTECHNOLOGY CO LTD

Application of exogenous complexing control measures in reducing low-temperature early flowering of tobacco

The application of exogenous complex control measures in reducing tobacco low temperature early flowering, after tobacco transplanting, before the arrival of low temperature cold damage, exogenous complex measures solution is sprayed; the exogenous complex chemical measures solution is the mixed solution of magnesium sulfate and salicylic acid. The invention uses low temperature sensitive tobacco variety Yunyan 87 as experimental material, compares and analyzes the changes of leaf phenotype, physiology and biochemistry indexes of Yunyan 87 seedlings under low temperature stress and various exogenous material treatment, and confirms the role of the complex measures in resisting cold stress. The low temperature adversity resistance of tobacco seedling stage plants is improved by using suitable concentration magnesium sulfate to spray the tobacco seedlings, so that the growth state of the tobacco seedlings subjected to the low temperature adversity stress of the reverse spring cold tends to be normal, the frost injury and frost death phenomenon of the tobacco seedlings after the cold stress is reduced, the cold resistance of the tobacco seedling stage is improved, the early flowering in the later period is prevented, and the operation is simple, the cost is low, and the effect is obvious.
Owner:CROP RES INST GUANGDONG ACAD OF AGRI SCI +1

Immunotoxicity analysis and evaluation method and system

The invention relates to the field of biological immunity, and discloses an immunotoxicity analysis and evaluation method and system.The method comprises the steps that immune cells and non-immune cells are cultured, an immune microenvironment of immune cell tissue is constructed, and an in-vitro immune system model of a human body is constructed; inputting an allogenic material into the in-vitro immune system model, and detecting cellular immune parameters of the experimental in-vitro immune system model; the method comprises the following steps: extracting a mouse genome of a mouse, constructing a gRNA-Cas9 compound of a target immune gene, implanting the gRNA-Cas9 compound into a preset mouse fertilized egg, culturing the target gene fertilized egg into a target gene mouse, inputting an exogenous material into the body of the target gene mouse, and analyzing humoral immune parameters of a blood sample; detecting organ parameters of the immune organs, calculating organ coefficients of the immune organs, and analyzing immune organ states of the immune organs; and analyzing an immunotoxicity evaluation report of the allogenic material on the human immune system. According to the invention, the accuracy of immunotoxicity analysis can be improved.
Owner:SUZHOU SAIFU NEW DRUG TECH SERVICE CO LTD +1

Bacterial recombinant collagen as well as preparation method and application thereof

The invention discloses a bacterial recombinant collagen as well as a preparation method and application thereof, and relates to the technical field of genetic engineering. The amino acid sequence of the bacterial recombinant collagen is as shown in SEQ ID NO. 1. The method can effectively promote cartilage repair, can be used as an alternative collagen-like biological material platform, provides a new method for cartilage repair, osteoarthritis and other diseases, and can also be used as an important exogenous material in cartilage repair scaffolds.
Owner:NORTHWEST UNIV

Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal, endoplasmic reticulum localization signal motifs

PendingUS20220267384A1Strong cytotoxicityAntibacterial agentsNervous disorderAntigenType specific
The present invention provides proteins comprising binding regions for cell-type specific targeting, Shiga toxin effector regions derived from A Subunits of members of the Shiga toxin family for providing Shiga toxin effector functions (e.g. cellular internalization and cytotoxicity), and carboxy-terminal endoplasmic reticulum localization signal motifs. The presently disclosed proteins can comprise additional exogenous materials, such as, e.g., antigens, cytotoxic agents, and detection-promoting agents, and are capable of targeted delivery of these additional exogenous materials into the interiors of target cells. The proteins of the present invention have uses in methods such as, e.g., methods involving targeted killing of target cells, delivering exogenous materials into target cells, labeling subcellular compartments of target cells, and diagnosing and / or treating a variety of conditions including cancers, tumors, other growth abnormalities, immune disorders, and microbial infections.
Owner:MOLECULAR TEMPLATES

Bacterial recombinant collagen, preparation method and application

The present invention discloses a bacterial recombinant collagen protein, a preparation method and an application thereof, and relates to the field of genetic engineering technology. The amino acid sequence of the bacterial recombinant collagen protein is shown in SEQ ID NO.1. The present invention can effectively promote cartilage repair, can be used as an alternative collagen-like biomaterial platform, provides a new method for cartilage repair, osteoarthritis and other diseases, and can also be used as an important exogenous material in cartilage repair scaffolds.
Owner:NORTHWEST UNIV

N-substituted thiazolidone compound and application thereof

The invention discloses an N-substituted thiazolidinone compound, and particularly relates to 2-phenylimino-N-(3-methoxy propyl)-5-(2, 4, 5-trimethoxy benzylidene) thiazolidinone and application of the 2-phenylimino-N-(3-methoxy propyl)-5-(2, 4, 5-trimethoxy benzylidene) thiazolidinone as a blocking agent of an aromatic hydrocarbon receptor signal channel. According to the invention, experiments prove that the compound can effectively inhibit the up-regulation of gene and protein expression of a metabolic enzyme CYP1A1 of an exogenous material related to a downstream target gene of an aromatic hydrocarbon receptor in mouse liver cancer cells caused by TCDD at the concentration of 10 [mu]M, so that it is prompted that the compound takes an aromatic hydrocarbon receptor as a target, can effectively block the activation of an aromatic hydrocarbon receptor signal channel, reduces the damage of multi-aromatic ring pollutants to an organism through the aromatic hydrocarbon receptor signal channel, and has wide clinical application prospects and economic development values.
Owner:HANGZHOU INST FOR ADVANCED STUDY UCAS

Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene

This invention provides a method for reversing cancer phenotype of a cancer cell which comprises introducing an exogenous material which is capable of specifically recognizing either a Prostate Tumor Inducing Gene, RNA of said gene or gene product of said gene into the cell under conditions permitting inhibition of the expression of said gene or function of said gene product so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a method for reversing cancer phenotype of a cancer cell in a subject which comprises introducing an exogenous material which is capable of specifically recognizing a Prostate Tumor Inducing Gene, RNA of said gene or gene product of said gene into the subject's cancer cell under conditions permitting inhibition of the expression of said gene or function of said gene product in the subject's cell so as to thereby reverse the cancerous phenotype of the cell.
Owner:FISHER PAUL

Nano-enhanced optical delivery of exogenous molecules to cells and tissues

ActiveUS10857238B2Low cytotoxicitySignificant translational potentialPowder deliveryMaterial nanotechnologyGene deliveryIn vivo
Principles of the present disclosure are directed to novel methods and devices for efficient and targeted delivery of impermeable exogenous materials such as small molecules, proteins, antibodies, and genes into cells, both in vitro as well as in vivo, which is of great importance for drug, vaccine and gene delivery for various therapeutic applications. Specifically, the invention provides device and method for targeted nano-enhanced optical delivery of opsins for vision restoration in patients with retinal photodegeneration by conventional intravitreal / sub-retinal injection of gold nano-rods and opsin plasmids followed by scanned / spatially modulated laser beam matching the pathological areas determined by Fundoscopy, OCT or scanning ophthalmoscope.
Owner:NANOSCOPE TECH LLC

Large volume ex vivo electroporation method

An object of the invention is to provide an electroporation method for treating vesicles with exogenous material for insertion of the exogenous material into the vesicles which includes the steps of: a. retaining a suspension of the vesicles and the exogenous material in a treatment volume in a chamber which includes electrodes, wherein the chamber has a geometric factor (cm.sup.−1) defined by the quotient of the electrode gap squared (cm.sup.2) divided by the chamber volume (cm.sup.3), wherein the geometric factor is less than or equal to 0.1 cm.sup.−1, wherein the suspension of the vesicles and the exogenous material is in a medium which is adjusted such that the medium has conductivity in a range spanning 50 microSiemens / cm to 500 microSiemens / cm, wherein the suspension is enclosed in the chamber during treatment, and b. treating the suspension enclosed in the chamber with one or more pulsed electric fields. With the method, the treatment volume of the suspension is scalable, and the time of treatment of the vesicles in the chamber is substantially uniform.
Owner:CELLECTIS SA

Intracellular delivery method

A method and device for transfecting a cell to introduce an exogenous material into the cell. The method includes exposing the cell to a region of unsteady flow in the presence of an electric field to encourage introduction of the exogenous material into a cell without lysing the cell.
Owner:INDEE PTY LTD

Exogenous material introduction method suitable for large-scale oyster egg cells

The invention discloses an allogenic material introduction method suitable for large-scale oyster egg cells, and belongs to the technical field of marine organisms. Comprising the following steps: (1) dissecting oysters to obtain egg cells, then mixing nucleic acid molecules to be delivered with a transfection reagent to prepare a transfection system, and mixing protein molecules capable of self-assembling to form a condensation body with the nucleic acid molecules in a buffer solution to form a protein-nucleic acid condensation body compound, the transfection reagent contains protein molecules which can be self-assembled to form a condensation body; and (2) mixing seawater containing egg cells with the protein-nucleic acid aggregate compound, incubating, and terminating the reaction. The method is convenient to operate, large in transfection flux and small in damage to cell morphology. The method is suitable for transfection systems of various sizes, and by taking a six-hole cell culture plate as an example, about 8 * 10 < 4 > egg cells can be simultaneously transfected in one hole at most under the condition that the final culture system is about 2ml.
Owner:SOUTH CHINA SEA INST OF OCEANOLOGY CHINESE ACAD OF SCI

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

ActiveUS11142584B2Rapid cellular internalizationSsRNA viruses negative-senseViral antigen ingredientsCD20Antigen
The present invention provides CD20-binding proteins that bind to and rapidly internalize in a CD20-mediated fashion from a cell surface location to the interior of the cell. CD20-binding proteins of the invention comprise a CD20 binding region and a Shiga toxin effector region. Certain of the disclosed CD20-binding proteins kill cells that express CD20 on their surface. Further, the presently disclosed CD20-binding proteins can comprise additional exogenous materials, such as, e.g., antigens, and are capable of targeted delivery of these additional exogenous materials into the interior of CD20 expressing cells. These CD20-binding proteins have uses in methods such as, e.g., methods involving the efficient cellular internalization of CD20, targeted killing of CD20 expressing cells, delivering exogenous materials inside CD20 expressing cells, detecting CD20 expressing cells, and treating a variety of conditions involving CD20 expressing cells including cancers, tumors, growth abnormalities, and immune disorders.
Owner:MOLECULAR TEMPLATES

Molybdenum complex & test kit to enhance accuracy of analysis of endogenous analytes in biological fluids

Methods for enhancement in accuracy of immunochemical analysis of heterogeneous biological fluids containing exogenous substances that can interfere in immunochemical analysis for endogenous analytes of interest. According to this method a heterogeneous biological fluid sample is pretreated with an interferant suppression effective amount of a molybdenum coordination complex, so as to reduce manifestation of the presence of said exogenous material under immunoassay conditions. This invention is suitable for the suppression of manifestation of exogenous substances, specifically metabolites of drugs of abuse, during the immunoassay of biological fluids of infants for detection of endogenous substances indicative of a wellness or disease state. This invention also has application for similar suppression exogenous substances in the biological fluid of adults that have been inadvertently exposed to such substances (e.g. secondhand smoke).
Owner:STEPHENS JAMES MATTHEW

Method for the optoinjection of exogenous material into a biological cell

A method for the optoinjection of exogenous material in a recipient biological cell is disclosed and comprises: placing a biological cell on a planar surface of a substrate, transmitting a sub-ns pulsed laser beam through a variable convergence / divergence collimator; focusing the laser beam in a focal spot positioned along an axial direction substantially perpendicular to the substrate; moving the focal spot towards the cell along the axial direction by continuously varying the electric control signal from a first amplitude value a second amplitude value the second amplitude value of the control signal is selected such that the second axial position is positioned inside the cell.
Owner:FOND INST ITAL DI TECH

Automated biological sample collection system and methods

An automated biological sample collection system and methods are disclosed. The system comprises an incubator, an applicator and a sampler. The incubator is configured to control the environment of a plurality of eggs, the applicator is configured to deliver exogenous material to the plurality of eggs, at least one sampler is configured to collect samples from the plurality of eggs, invasively or non-invasively and a system controller is operable to drive the various components of the system automatically according to assay specifications and configuration.
Owner:INNOVO MIMETICS

Conjugate based on nucleic acid material supported platinum drug, platinum drug delivery system as well as preparation method and application of platinum drug delivery system

PendingCN111803517AReduce irreversible binding reactionsLow degradabilityInorganic active ingredientsNanomedicineNucleotideTherapeutic effect
The invention discloses a conjugate based on nucleic acid material supported platinum drug, a platinum drug delivery system as well as a preparation method and application of the platinum drug delivery system. The conjugate based on the nucleic acid material supported platinum drug comprises a block functional nucleic acid framework and platinum prodrug molecules grafted on the nucleic acid framework, wherein one end of the nucleic acid framework is a functional nucleic acid sequence with a phosphodiester bond, and the other end is a thiophosphate-modified nucleotide sequence, and after graftmodification of the platinum drug with the thiophosphate, a nucleic acid nano-drug is formed by self-assembly by using amphipathicity. The biocompatible nucleic acid material is used to deliver the platinum drug, and no other exogenous materials are used as a hydrophobic core, and multi-site graft loading and nanostructure assembly of the platinum drug can be realized only through simple block nucleic acid and drug graft modification on the phosphorothioate block. The nano-drug has a high drug loading rate, and can conveniently realize the introduction of targeted nucleic acid sequences and the combined therapeutic effect of chemotherapy and gene therapy.
Owner:SHANGHAI JIAO TONG UNIV